Can Brain Volume-Driven Characteristic Features Predict the Response of Alzheimer's Patients to Repetitive Transcranial Magnetic Stimulation? A Pilot Study

Chandan Saha,Chase R. Figley,Brian Lithgow,Paul B. Fitzgerald,Lisa Koski,Behzad Mansouri,Neda Anssari,Xikui Wang,Zahra Moussavi
DOI: https://doi.org/10.3390/brainsci14030226
IF: 3.333
2024-02-29
Brain Sciences
Abstract:This study is a post-hoc examination of baseline MRI data from a clinical trial investigating the efficacy of repetitive transcranial magnetic stimulation (rTMS) as a treatment for patients with mild–moderate Alzheimer's disease (AD). Herein, we investigated whether the analysis of baseline MRI data could predict the response of patients to rTMS treatment. Whole-brain T1-weighted MRI scans of 75 participants collected at baseline were analyzed. The analyses were run on the gray matter (GM) and white matter (WM) of the left and right dorsolateral prefrontal cortex (DLPFC), as that was the rTMS application site. The primary outcome measure was the Alzheimer's disease assessment scale—cognitive subscale (ADAS-Cog). The response to treatment was determined based on ADAS-Cog scores and secondary outcome measures. The analysis of covariance showed that responders to active treatment had a significantly lower baseline GM volume in the right DLPFC and a higher GM asymmetry index in the DLPFC region compared to those in non-responders. Logistic regression with a repeated five-fold cross-validated analysis using the MRI-driven features of the initial 75 participants provided a mean accuracy of 0.69 and an area under the receiver operating characteristic curve of 0.74 for separating responders and non-responders. The results suggest that GM volume or asymmetry in the target area of active rTMS treatment (DLPFC region in this study) may be a weak predictor of rTMS treatment efficacy. These results need more data to draw more robust conclusions.
neurosciences
What problem does this paper attempt to address?
The problem that this paper attempts to solve is: Can the response of Alzheimer's disease (AD) patients to repetitive transcranial magnetic stimulation (rTMS) treatment be predicted by analyzing baseline magnetic resonance imaging (MRI) data? Specifically, the researchers hope to explore whether the gray matter (GM) and white matter (WM) volumes and their asymmetry in specific brain regions (especially the bilateral dorsolateral prefrontal cortex, DLPFC) can be used as indicators to predict the efficacy of rTMS treatment. ### Research Background - **Effectiveness of rTMS in Treating AD**: In recent years, rTMS has been widely studied for the treatment of Alzheimer's disease (AD), and multiple studies have shown that it has a certain effect in improving cognitive function. - **Challenges of Treatment Protocols**: Although rTMS shows potential, its treatment protocols usually require daily treatment for 2 - 6 weeks continuously, and sometimes even up to 6 months of maintenance treatment. This brings a relatively large burden to patients and their families. - **Individual Differences**: Not all patients respond positively to rTMS treatment, and some patients' conditions even worsen after receiving treatment. Therefore, being able to predict patients' treatment responses in advance is crucial for formulating personalized treatment strategies. ### Research Objectives - **Predict rTMS Treatment Response**: Predict patients' responses to rTMS treatment by analyzing the baseline MRI data of AD patients, especially the gray matter and white matter volumes and their asymmetry in the DLPFC region. - **Explore Potential Biomarkers**: Look for brain structural features that may be used as predictors of rTMS treatment efficacy to improve the personalization and effectiveness of treatment. ### Methods - **Participants**: The study included 75 AD patients who received rTMS treatment. According to their treatment responses, they were divided into responders (42 people) and non - responders (20 people). - **MRI Data Analysis**: Use Voxel - Based Morphometry (VBM) technology to analyze the T1 - weighted MRI data of the participants, extract the gray matter and white matter volumes in the DLPFC region, and calculate the asymmetry index. - **Statistical Analysis**: Use analysis of covariance (ANCOVA) to compare the volume differences between responders and non - responders, and use a logistic regression model to evaluate the prediction performance. ### Results - **Volume Differences**: The gray matter volume in the right DLPFC region of responders was significantly lower than that of non - responders (p = 0.004). - **Asymmetry Differences**: The gray matter asymmetry index in the DLPFC region of responders was significantly higher than that of non - responders (p = 0.009). - **Prediction Performance**: Using a logistic regression model, combined with the gray matter volume and asymmetry index in the right DLPFC region, the accuracy rate of predicting responders was 0.69, and the AUC was 0.74. ### Conclusions - **Preliminary Results**: The gray matter volume and asymmetry in the DLPFC region may be weak indicators for predicting the efficacy of rTMS treatment. - **Future Directions**: More data and further research are needed to verify these preliminary findings and explore other potential prediction indicators. Through these studies, scientists hope to better understand the mechanism of rTMS in treating AD and provide more effective treatment suggestions for clinicians.